S&P 500

Bio-Techne (TECH) — 10-Year DCF Projection Model

Free stock research tool. Build a 10-year revenue, earnings (EPS), and free cash flow forecast for Bio-Techne (TECH) stock, a company in the Health Care (Life Sciences Tools & Services) sector. Pulls audited SEC EDGAR XBRL financials, triangulates Wall Street analyst consensus across Yahoo Finance, NASDAQ, and StockAnalysis, and overlays AI-clustered news + social event probabilities directly onto projected EPS. For equity research — not personal budgeting or accounting.

Build TECH projection model →Browse all stocks

Bio-Techne at a glance

Ticker
TECH
Company
Bio-Techne
Sector
Health Care
Sub-industry
Life Sciences Tools & Services
Headquarters
Minneapolis, Minnesota
Founded
1976
Added to S&P 500
2021-08-30
Index membership
S&P 500

What you'll see in your TECH model

  • 10 years of audited historical financials for Bio-Techne, sourced directly from the SEC's EDGAR XBRL filings (10-K and 10-Q).
  • Triangulated Wall Street consensus for TECH's forward revenue, EBITDA, and EPS across Yahoo Finance, NASDAQ, and StockAnalysis with cross-source dispersion (σ).
  • AI Event Factors: top-10 news/social themes for TECH with probability sliders and live EPS impact.
  • Sensitivity tables and Excel export for every assumption.

About Bio-Techne

Bio-Techne (NYSE/NASDAQ: TECH) was founded in 1976 and is headquartered in Minneapolis, Minnesota. The company operates in the Health Care sector (Life Sciences Tools & Services sub-industry) and is a constituent of the S&P 500. Our projection model builds a clean discounted-cash-flow view of Bio-Techne in roughly five seconds and lets you adjust every assumption to test your own thesis.